Svenja Zapf

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro Models.

Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro Models.

Journal: Molecular pharmaceutics

Published: September 21, 2023

Glioma escape signature and clonal development under immune pressure.

Glioma escape signature and clonal development under immune pressure.

Journal: The Journal of clinical investigation

Published: April 02, 2020

Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments.

Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments.

Journal: PloS one

Published: December 17, 2018

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 07, 2017

Optical Barcoding for Single-Clone Tracking to Study Tumor Heterogeneity.

Optical Barcoding for Single-Clone Tracking to Study Tumor Heterogeneity.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 20, 2016

Persistent Detwinning of Iron-Pnictide EuFe_{2}As_{2} Crystals by Small External Magnetic Fields.

Persistent Detwinning of Iron-Pnictide EuFe_{2}As_{2} Crystals by Small External Magnetic Fields.

Journal: Physical review letters

Published: March 27, 2014

Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ.

Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ.

Journal: Neuro-oncology

Published: July 24, 2013

EuFe2(As(1-x)P(x))2: reentrant spin glass and superconductivity.

EuFe2(As(1-x)P(x))2: reentrant spin glass and superconductivity.

Journal: Physical review letters

Published: March 19, 2013

Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.

Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 10, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026